Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Frampton

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
The Lancet. Oncology|July 4, 2012
Raising a glass of red wine against cancer, or not?Adam E Frampton, Justin Stebbing
The New England Journal of Medicine|January 5, 2022
A New Combination Immunotherapy in Advanced MelanomaAdam E Frampton, Shivan Sivakumar
Future Oncology (London, England)|August 17, 2012
Cancer vaccines: is prevention better than cure?Adam E Frampton, Jonathan Krell
Journal of Clinical Pathology|August 14, 2013
Gene of the month: E-cadherin (CDH1)Tamara M H Gall, Adam E Frampton
Frontiers in Bioscience (Elite Edition)|January 2, 2013
MicroRNAs in the cancer clinicJonathan Krell, Adam E Frampton, Justin Stebbing
BMC Cancer|April 5, 2012
The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?Jonathan Krell, Adam E Frampton, Justin Stebbing
Expert Review of Medical Devices|December 7, 2013
Challenges facing in vivo tracking of mesenchymal stem cells used for tissue regenerationMohammad A Hossain, Adam E Frampton, Atul Bagul
Annals of Surgery|October 9, 2013
Integrating the evidence for single-incision laparoscopic cholecystectomy: is it "looking" good?Madhava Pai, Adam E Frampton, Long R Jiao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2013
Serum miR-1290 as a marker of pancreatic cancer--letterAdam E Frampton, Jonathan Krell, Geert Kazemier, et al.
Expert Review of Cardiovascular Therapy|November 30, 2012
Individualizing hemodynamic optimization during the management of circulatory collapseAlexander M Fletcher, Jeremy Ch Andrews, Adam E Frampton
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The Lancet. Oncology|July 4, 2012
Raising a glass of red wine against cancer, or not?Adam E Frampton, Justin Stebbing
The New England Journal of Medicine|January 5, 2022
A New Combination Immunotherapy in Advanced MelanomaAdam E Frampton, Shivan Sivakumar
Future Oncology (London, England)|August 17, 2012
Cancer vaccines: is prevention better than cure?Adam E Frampton, Jonathan Krell
Journal of Clinical Pathology|August 14, 2013
Gene of the month: E-cadherin (CDH1)Tamara M H Gall, Adam E Frampton
Frontiers in Bioscience (Elite Edition)|January 2, 2013
MicroRNAs in the cancer clinicJonathan Krell, Adam E Frampton, Justin Stebbing
BMC Cancer|April 5, 2012
The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?Jonathan Krell, Adam E Frampton, Justin Stebbing
Expert Review of Medical Devices|December 7, 2013
Challenges facing in vivo tracking of mesenchymal stem cells used for tissue regenerationMohammad A Hossain, Adam E Frampton, Atul Bagul
Annals of Surgery|October 9, 2013
Integrating the evidence for single-incision laparoscopic cholecystectomy: is it "looking" good?Madhava Pai, Adam E Frampton, Long R Jiao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2013
Serum miR-1290 as a marker of pancreatic cancer--letterAdam E Frampton, Jonathan Krell, Geert Kazemier, et al.
Expert Review of Cardiovascular Therapy|November 30, 2012
Individualizing hemodynamic optimization during the management of circulatory collapseAlexander M Fletcher, Jeremy Ch Andrews, Adam E Frampton
Pageof 17